Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Sodium valproate----3件: 2, 102, 256 💬
2Sodium valproate 200 MG gastro-resistant tablets----1件: 233 💬
3Sodium valproate 200MG E/C tablet----1件: 233 💬
4Sodium valproate wockhardt 200MG gastro-resistant tablets----1件: 233 💬
5Valproic acid
(Sodium valproate)		1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium (Sodium valproate) 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
6Valproic acid and levocarnitine
(Sodium valproate)		1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium (Sodium valproate) 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬